SIZE XSSIZE SMSIZE MDSIZE LG

BCOP Self-Study Online Module Bundle

$300 (member) / $420 (non-member)

Purchase now (Purchase provides access to Release I and Release II)

The Self-Study Online Module Bundle provides new high quality professional development education and features a series of current articles from primary oncology literature on demand and at your convenience.

  • Leading experts from a variety of specialties and settings
  • Therapeutic developments translated into case-based reviews
  • Application of information to practice based scenarios
  • Credit given per module – choose one or all

Credits: Up to 15 hours of BCOP and ACPE credit with completion of both releases.
BCOP credits are available for Release I to earn until October 27, 2018.

BCOP credits are available for Release II to earn until March 29, 2019.

Release I

  • Module 1: Hodgkin Lymphoma: Where Do All the Pieces Fit? (1.5 BCOP/ACPE)
  • Module 2: Updates in the Treatment of Acute Myeloid Leukemia (2.5 BCOP/ACPE)
  • Module 3: Biomarkers in Immunotherapy (1.5 BCOP/ACPE)
  • Module 4: Treatment of NSCLC with a Focus on Newer Therapies (2.5 BCOP/ACPE)

Learn more about BCOP Online Module Release I.

Release II

  • Module 5: TBA (2 hours)
  • Module 6:TBA (2 hours)
  • Module 7:TBA (1.5 hours)
  • Module 8: TBA (1.5 hours)

Each module will include access to articles, pre-assessment questions, patient cases and/or case—based discussion/questions and the BCOP posttest. Your purchase includes all four modules. You may choose to complete all 4 modules or select modules individually and still receive BCOP credit for modules which achieve passing scores. Participants will complete the patient case/case-based questions and the posttest for each module and must achieve a 75% combined passing grade to obtain BCOP Recertification credit for that module.

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists.

Activity Type:

Application

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved. BCOP credits for Release I are available until October 27, 2018 and BCOP credits for Release II are available until March 29, 2019.

education speaker bpslogoThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved. BCOP credits for Release I are available until October 27, 2018 and BCOP credits for Release II are available until March 29, 2019.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

$300 (member) / $420 (non-member)

Purchase now (Purchase provides access to Release I and Release II)

This can also be purchased as part of the 2018 BCOP Program Bundle.

xs
sm
md
lg